Inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis
(UC), is a heterogeneous state of chronic intestinal inflammation with no exact known cause …

Accounting for almost one-third of the global mortality, cardiovascular diseases (CVDs)
represent a major global health issue. Emerging data suggest that most of the well …

A specific diet regimen is a promising way of managing inflammatory bowel disease (IBD),
with the Mediterranean diet (MD) being a likely candidate due to its potential to modulate gut …

Accumulating data suggests that catestatin, an eclectic neuroendocrine peptide, is involved
in the pathophysiology of primary hypertension (PH). Nevertheless, clinical studies …

Aim A “leaky” gut barrier has been implicated in the initiation and progression of a multitude
of diseases, for example, inflammatory bowel disease (IBD), irritable bowel syndrome and …

Catestatin (CST) is a pleiotropic peptide involved in cardiovascular protection with its
antihypertensive and angiogenic effects. Considering that patients with end-stage renal …

With the rising global burden of inflammatory bowel disease (IBD) and the rising costs of
novel biological drugs, there is an increasing need for dietary approaches and functional …

Catestatin (CST) is a pleiotropic peptide with cardioprotective and metabolic effects. CST is
involved in the pathogenesis of both arterial hypertension (AH) and type 2 diabetes mellitus …

Population-based studies have suggested that patients with inflammatory bowel disease
(IBD) might be at an increased risk for cardiovascular diseases. A meta-analysis was …

As early commencement of inflammatory bowel disease (IBD) treatment has been shown to
substantially improve outcomes, it is of utmost importance to make a timely diagnosis of this …